Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.
2.

[Cytological diagnosis of lymph nodes by instrumental guide: ultrasonography and CT].

D'Amico G, Di Crescenzo V, Muto M, Amato M, Grassi R, Lanza J, Garzi A, Vitale M.

Recenti Prog Med. 2013 Jul-Aug;104(7-8):367-70. doi: 10.1701/1315.14577. Review. Italian.

PMID:
24042409
3.

Lymph node fine needle cytology in the diagnosis of infectious diseases and reactive unspecific processes.

Cipullo C, Amato B, Vigliar E, Di Crescenzo V, Zeppa P.

Infez Med. 2012;20 Suppl 3:30-3.

4.

Lymph nodes Fine Needle Cytology in the diagnosis of infectious diseases: cytological and histological correlations.

Cozzolino I, Scognamiglio G, Sosa Fernandez LV, Zeppa P.

Infez Med. 2012;20 Suppl 3:16-20.

5.
6.

Lymph node fine needle cytology in the diagnosis of infectious diseases and ancillary techniques.

Sosa Fernandez LV, Plaitano F, Varone V, Cozzolino I.

Infez Med. 2012;20 Suppl 3:21-5.

7.

Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.

An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.

Nuklearmedizin. 2014;53(3):89-94. doi: 10.3413/Nukmed-0605-13-06.

PMID:
24220324
8.
9.

Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.

Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.

Acta Radiol. 2015 Aug;56(8):917-23. doi: 10.1177/0284185114539786.

PMID:
25013091
10.

Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.

Tan R, Yao SZ, Huang ZQ, Li J, Li X, Tan HH, Liu QW.

Asian Pac J Cancer Prev. 2014;15(18):7719-24.

11.

Lymph nodes fine needle cytology in the diagnosis of infectious diseases: clinical settings.

Natella V, Cozzolino I, Sosa Fernandez LV, Vigliar E.

Infez Med. 2012;20 Suppl 3:12-5.

12.
13.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

16.

Lymph node and lymphoid organs fine needle aspiration cytology: historical background.

Cozzolino I, Vigliar E, Vetrani A, Zeppa P.

Infez Med. 2012;20 Suppl 3:8-11.

17.

Comparison of 19- and 22-gauge needles in EUS-guided fine needle aspiration in patients with mediastinal masses and lymph nodes.

Songür N, Songür Y, Bırcan S, Kapucuoğlu N.

Turk J Gastroenterol. 2011 Oct;22(5):472-8.

18.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
19.

Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.

Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, Uzan C, Lumbroso S, Lecuru F, Bats AS, Ghazzar N, Bannier M, Houvenaeghel G, Brenot-Rossi I, Narducci F.

Ann Surg Oncol. 2011 Aug;18(8):2302-9. doi: 10.1245/s10434-011-1583-9.

PMID:
21347790
20.

Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.

Deron PB, Bonte KM, Vermeersch HF, Van de Wiele C.

Cancer Biother Radiopharm. 2011 Jun;26(3):331-4. doi: 10.1089/cbr.2010.0918.

PMID:
21711095
Items per page

Supplemental Content

Support Center